Medical Xpress November 10, 2025
Hundreds of health care artificial intelligence (AI) tools have been cleared by the U.S. Food and Drug Administration (FDA), yet only a fraction are rigorously evaluated for clinical impact, fairness or bias. Furthermore, the FDA review only covers a small portion of health AI tools being developed and used in health care. The American Heart Association (Association), a global force changing the future of health for all, today released a new science advisory urging health systems to adopt clear and simple rules for using AI in patient care.
Published in the Association’s flagship journal, Circulation, the advisory, “Pragmatic Approaches to the Evaluation and Monitoring of Artificial Intelligence in Health Care,” introduces a pragmatic, risk-based framework for evaluating and monitoring artificial...
Today's Sponsors
Today's Sponsor